Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers

ABSTRACT: Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers

PROVIDER: PRJNA634242 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers

Project description:To directly compare genomic alterations between patient tumors and derived cell lines, both parental tumors and cell lines were characterized by array-based comparative genomic hybridization.

2020-10-27 | GSE150963 | GEO

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers.

Project description:Human cancer cell lines are frequently used as model systems to study molecular mechanisms and genetic changes in cancer. However, the model is repeatedly criticized for its lack of proximity to original patient tumors. Therefore, understanding to what extent cell lines cultured under artificial conditions reflect the phenotypic and genomic profiles of their corresponding parental tumors is crucial when analyzing their biological properties. To directly compare molecular alterations between patient tumors and derived cell lines, we have established new cancer cell lines from four patients with gastrointestinal tumors. Tumor entities comprised esophageal cancer, colon cancer, rectal cancer and pancreatic cancer. Phenotype and genotype of both patient tumors and derived low-passage cell lines were characterized by immunohistochemistry (22 different antibodies), array-based comparative genomic hybridization and targeted next generation sequencing (48-gene panel). The immunophenotype was highly consistent between patient tumors and derived cell lines; the expression of most markers in cell lines was concordant with the respective parental tumor and characteristic for the respective tumor entities in general. The chromosomal aberration patterns of the parental tumors were largely maintained in the cell lines and the distribution of gains and losses was typical for the respective cancer entity, despite a few distinct differences. Cancer gene mutations (e.g., KRAS, TP53) and microsatellite status were also preserved in the respective cell line derivates. In conclusion, the four examined newly established cell lines exhibited a phenotype and genotype closely recapitulating their parental tumor. Hence, newly established cancer cell lines may be useful models for further pharmacogenomic studies.

| S-EPMC7578805 | biostudies-literature

mRNA expression profiles of newly established 49 gastric cancer cell lines.

Project description:mRNA expression profiles of newly established 49 gastric cancer cell lines.

| PRJNA722410 | ENA

mRNA expression profiles of 223 cancer cell lines including newly established ones

Project description:mRNA expression profiles of 223 cancer cell lines including newly established ones

| PRJNA722281 | ENA

Biological and genetic characterization of a newly established human external auditory carcinoma cell line, SCEACono2

Project description:Biological and genetic characterization of a newly established human external auditory carcinoma cell line, SCEACono2

| PRJNA1003126 | ENA

Biological and genetic characterization of a newly established human external auditory carcinoma cell line, SCEACono2

Project description:Squamous cell carcinoma of the external auditory canal (EACSCC) is an extraordinarily rare and aggressive malignant disease. Establishment of EACSCC cell line with robust molecular characteristics is essential for the basic and translational research of EACSCC. In this study, we showed the newly established EACSCC cell line SCEACono2, derived from a patient with well-to-moderately differentiated EACSCC. To elucidate the transctomic features of SCEACono2, we performed RNA-seq and revealed its unique characteristics and compared with publicly available head and neck squamous cell caricnoma (HNSCC)-derived cell lines HSC4 and SCC9.

2023-11-07 | GSE240311 | GEO

Global gene expression profiling using newly synthesized RNA [mock and LPS]

Project description:Innate stimulation with TLR ligands leads to the activation of various genes in macrophages and various populations of these cells may exhibit different responses. Here wanted to delineate and characterize these transcriptional responses in newly established, self-renewing, in vitro grown non-transformed lines (MPI cells) and bone marrow derived macrophages We used microarrays to detail the global programme of gene expression Newly synthesized RNA from independently established MPI lines and bone marrow derived macrophages was extracted and hybridized to Affymetrix microarrays

2013-06-08 | E-GEOD-47530 | biostudies-arrayexpress

mRNA expression profiles of newly established 49 gastric cancer cell lines.

Project description:Establishment and molecular characterization of 49 peritoneally-metastatic gastric cancer cell lines from 18 patients’ ascites. We performed comprehensive transcriptome analyses using microarrays of our established gastric cancer cell lines.

2023-04-01 | GSE172197 | GEO

Proteomic reveals reasons for acquired drug resistance in lung cancer derived brain metastasis based on a newly established multi-organ microfluidic chip model

Project description:Anti-tumor drugs can effectively shrink the lesions of primary lung cancer; however, it has limited therapeutic effect on patients with brain metastasis (BM). A BM preclinical model based on a multi-organ microfluidic chip has been established proficiently in our previous work. In this study, the BM subpopulation (PC9-Br) derived from the parental PC9 cell line was isolated from the chip model and found to develop obvious resistance to antineoplastic drugs including chemotherapeutic agents (cisplatin, carboplatin, pemetrexed) and tyrosine kinase inhibitors (TKIs) which target epidermal growth factor receptor (EGFR); this suggested that the acquisition of drug-resistance by brain metastatic cells was attributable to the intrinsic changes in PC9-Br. Hence, we performed proteomic and revealed a greatly altered spectrum of BM protein expression compared with primary lung cancer cells.

2021-09-09 | PXD021760 | Pride

RockDove Parental Care

Project description:RockDove Parental Care

| PRJEB28684 | ENA